Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 33 n° 244

Posts Tagged ‘researchers’

Researchers are closing in on long covid

Posted by fidest press agency su martedì, 4 maggio 2021

Welcome to our weekly newsletter highlighting The Economist’s best coverage of the pandemic and its effects. In our Science section, we look at how scientists are closing in on understanding “long covid”. Many months after their initial infection with covid-19, some people still suffer from a range of debilitating symptoms including severe breathlessness, fatigue or “brain fog”. How should countries respond to this impending public-health emergency? In a leader, we argue that health-care systems and employers must prepare to assist long-covid sufferers. We also cover the topic on “Babbage”, our science podcast.Many Indians are up in arms about the government’s handling of their country’s all-engulfing second wave of covid-19. Hospitals, testing facilities, even crematoria are overwhelmed. Vaccines are in short supply. But where the government may have fallen short, civil society has stepped up. We published a correspondent’s diary from Delhi, where “acquaintances are dying faster than they can be counted”, while in our sister magazine, 1843, Sudipto Sanyal wrote about the collapse of the health-care system in Kolkata. For many Australians, quarantine cannot be too tough. States there keep ordering snap lockdowns because they are nervous about more contagious strains of covid-19 and most foreigners are barred from entering the country. A poll in February found that 71% of Aussies want to keep the international border closed until the “public health crisis has passed”. America has locked up supplies of covid vaccines that it does not need. As global recorded cases of covid-19 reach the highest levels of the pandemic so far, President Joe Biden is pursuing a vaccination policy that might well be branded with a favourite tagline of his predecessor, Donald Trump: America First.Meanwhile, many countries have turned to China and Russia for help. A new report by the Economist Intelligence Unit (a sister company of The Economist) shows how the two are filling a “vaccine vacuum” by helping poor countries secure doses. They have shipped millions of jabs to those stuck at the back of the global queue. Venezuela’s despot, however, has been touting a herbal quack cure for covid-19—while hospitals lack water and vaccines are scarce.In an invited article, Ashish Jha, dean of the Brown University School of Public Health, makes the case for vaccine passports to beat covid-19. People will only have confidence meeting together for work or leisure, he argues, if they have some certainty it is safe. We also published a counter-argument by Clare Wenham of the London School of Economics and a reflection on Israel’s experience by Rachel Azaria, a former member of the Knesset.On “The Jab”, our podcast reporting from the sharp end of the vaccination race, we consider what lessons the world should learn after more than a year living with covid-19. Also, what explains the vast discrepancies in the ways the pandemic seems to have affected different countries? Zanny Minton Beddoes Editor-In-Chief The Economist

Posted in Estero/world news, Recensioni/Reviews | Contrassegnato da tag: , | Leave a Comment »

IQVIA Collaborates with Cancer Researchers to Advance Use of Real World Evidence

Posted by fidest press agency su sabato, 21 settembre 2019

IQVIA™ (NYSE:IQV) is proud to announce its collaboration with Friends of Cancer Research in a cross-industry effort to advance acceptance and drive future uses of real world evidence (RWE). This research helps confirm that clinical benefits seen for therapies in clinical trials were consistent with the benefits of those treatments within real world settings. RWE comprises dynamic data including assets such as EMR, hospital, pharmacy, and claims sources, as well as genomics, mobile health, and patient reported outcomes. The project is part of a Friends of Cancer Research initiative that is working to demonstrate the application of real world evidence in oncology research. As part of this project, a recent study involving six research centers in the U.S. followed a common protocol to assess real world endpoints among cancer patients, including overall survival, time to next treatment, time to treatment discontinuation, time to progression and progression-free survival. Results from the collaborative project, An Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients With Advanced Non–Small-Cell Lung Cancer, were recently published in JCO Clinical Cancer Informatics. Researchers used non-identified patient data from assets such as administrative claims and electronic health records to assess real world endpoints and found that they were generally consistent with each other and with outcomes observed in randomized clinical trials.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

New rules to attract non-EU students, researchers and interns to the EU

Posted by fidest press agency su martedì, 10 maggio 2016

scuola-digitale-casnati-como-800x500_cHarmonised EU entry and residence rules that will make it easier and more attractive for students and researchers from third countries to study or do research at EU universities are up for a final vote in Strasbourg on Wednesday. The new rules also have provisions to clarify and improve conditions for non-EU interns, volunteers, school pupils and au pairs, so as to facilitate cultural exchanges.
An informal agreement on the new rules was reached with Council in November last year.

Posted in Estero/world news, scuola/school | Contrassegnato da tag: , , | Leave a Comment »